NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 142 filers reported holding NEVRO CORP in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $938,000 | -53.0% | 15,000 | -40.0% | 0.02% | -52.1% |
| Q2 2018 | $1,996,000 | -45.8% | 25,000 | -41.2% | 0.05% | -59.0% |
| Q1 2018 | $3,683,000 | +11.1% | 42,500 | -11.5% | 0.12% | +37.6% |
| Q4 2017 | $3,314,000 | -19.0% | 48,000 | +6.7% | 0.08% | -44.1% |
| Q3 2017 | $4,090,000 | +44.6% | 45,000 | +18.4% | 0.15% | +27.7% |
| Q2 2017 | $2,828,000 | +50.9% | 38,000 | +90.0% | 0.12% | +60.8% |
| Q1 2017 | $1,874,000 | +134.5% | 20,000 | +81.8% | 0.07% | +89.7% |
| Q4 2016 | $799,000 | +27.6% | 11,000 | +83.3% | 0.04% | 0.0% |
| Q3 2016 | $626,000 | -41.8% | 6,000 | -58.8% | 0.04% | -53.0% |
| Q2 2016 | $1,075,000 | -34.1% | 14,580 | -49.7% | 0.08% | +16.9% |
| Q1 2016 | $1,632,000 | +157.0% | 29,000 | +208.5% | 0.07% | +65.1% |
| Q4 2015 | $635,000 | – | 9,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |